New blood test could sniff out lung cancer early
NCT ID NCT06261294
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study collected blood samples from 109 people with and without lung cancer to develop a blood test called OncoSweep Lung Spotlight. The test looks for genetic and other signals in the blood that might indicate lung cancer. Researchers hope this could lead to a simple, non-invasive way to help detect lung cancer earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- OncoSweep Lung Spotlight blood test
- What this could lead to
- If successful, this could lead to a simple blood test that helps doctors detect lung cancer earlier, potentially improving treatment outcomes.
- What could go wrong
- This is an early development study with only 109 participants. The test is not yet proven to work in real-world settings and may not be accurate enough for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mackay Memorial Hospital
Taipei, Zhongshan Dist, 104217, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection